If you are currently prescribed HGH by an NHS endocrinologist or specialist and are considering adding any other agent including retatrutide or other GLP-1-based medicines it is essential to discuss this with your prescribing clinician before making any changes
Three diabetes incretin medications are now approved for pediatric use starting at age 10 (see cheat sheet), and two incretin-based weight management medications are approved for children aged 12 and older
The SURMOUNT-3 trial, which added Tirzepatide after an intensive lifestyle lead-in, reported total weight reductions of up to 26.6%
Not yet available by prescription
Wilson JM, Nikooienejad A, Robins DA, et al
How It Works You sign up through an online questionnaire, followed by a short video visit with a qualified healthcare provider in most states, so its not fully asynchronous